# Tongjiang Series Prescription Combined With PPIs Descending Ladder Withdrawal in Treating Nonerosive Reflux Disease

> **NCT04340297** · PHASE3 · UNKNOWN · sponsor: **Xiyuan Hospital of China Academy of Chinese Medical Sciences** · enrollment: 180 (estimated)

## Conditions studied

- Nonerosive Reflux Disease

## Interventions

- **DRUG:** Tongjiang series prescription(Tongjiang granules, Jianpi Qinghua granules and Wenpi Qingwei granules)
- **DRUG:** Acid inhibitors
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04340297
- **Lead sponsor:** Xiyuan Hospital of China Academy of Chinese Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-06-15
- **Primary completion:** 2021-12-01
- **Final completion:** 2021-12-31
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2020-07-29

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04340297

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04340297, "Tongjiang Series Prescription Combined With PPIs Descending Ladder Withdrawal in Treating Nonerosive Reflux Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04340297. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*